The GMO U.S. Small Cap Value Strategy seeks to generate total return in excess of its benchmark, the S&P Small Cap 600 Value Index, by investing primarily in equities of U.S. companies that are included in the S&P 600 Index or whose market capitalization at the time of investment is less than that of companies in the bottom decile of market capitalization of the MSCI U.S. IMI Index. 

The Strategy’s investment approach is grounded in the Systematic Equity team’s belief that, in the short term, equity markets exhibit exploitable inefficiencies as a result of irrational investor actions, the imperfect flow of information, and the participation of non-economic actors, while in the long-term returns are ultimately driven by economic reality. The Strategy aims to take advantage of these inefficiencies by utilizing a multi-factor valuation model in conjunction with other methods, such as cross-asset signals and corporate alerts, to identify undervalued equity securities. 





Fact Sheet Download
Product Primer Download
GIPS® Composite Report Download
Download All Download


Performance Download
Portfolio Composition Download
Download All Download

Commentary & Attribution

Commentary Quarterly Download
Market Review Download
Year-End Letter Download
Attribution - Monthly Download
Attribution - Quarterly Download
Attribution - YTD Download
Download All Download


Risks associated with investing in the Strategy may include Market Risk-Equities, Management and Operational Risk, Small Company Risk, Focused Investment Risk and Illiquidity Risk.